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ABSTRACT 
Objective: The lack of possible cure and associated disadvantages of allopathic medicines in the topical treatment of psoriasis has led to extensive 
research for anti-psoriatic activities of plant-based drugs. The present study was aimed to develop topical cream formulation containing the 
Nanostructured Lipid Carriers of Azadirachta indica leaves extract (AE), Lawsonia inermis leaves extract (LE) and fruit extract of Mallotus philippensis 
(ME) and assessing the antipsoriatic activity of prepared cream formulation.  
Methods: The Drug loaded NLCs were prepared via hot homogenization technique and incorporated into the water in oil (w/o) cream base that 
was prepared by the emulsification method. Evaluation of cream formulation included advanced preclinical trials using Rat Ultraviolet Ray-B 
photodermatitis and Mousetail method, anti-lipid peroxidation assay, nitric oxide scavenging activity, cytotoxicity and DNA fragmentation on HaCat 
cell lines to ascertain antipsoriatic potential and in vitro drug diffusion. 
Results: In spite of the low amount of the drug loading in NLCs their potency was much higher as displayed in Advanced Preclinical studies and cell line 
studies for psoriasis indicating the suitability of NLCs loaded creams for skin applications due to their various desirable effects on the skin. Occlusive 
properties of the prepared NLC on the skin provide an increase in drug penetration particularly via skin moisturization. The in vitro drug diffusion studies 
suggest the prolonged and almost complete release of AE, LE and ME from NLC based cream up to 24 h that was found to be 81.24±0.51%, 74.31±0.25% and 
70.43±0.78% respectively. The literature survey supports the novelty of such topical anti-psoriatic polyherbal nanoparticulate cream. 
Conclusion: It can be concluded that the AE, LE and ME loaded NLC based cream can be used for prolonged topical delivery of drugs for the 
management of Psoriasis.  
Keywords: Herbal Anti-psoriatic Nanoparticulate Cream, Cell line study, Advanced Preclinical Trials 
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INTRODUCTION 
Psoriasis is an autoimmune skin disease that causes scaling and 
inflammation of the skin and occurs when the immune system sends 
out faulty signals that speed up the growth cycle of skin cells than 
normal [1-2]. The body does not shed these excess skin cells, 
thereby resulting in the piling up of cells on the surface of the skin 
that pose the problem of poor topical drug permeability [1]. The lack 
of possible cure and associated disadvantages of allopathic 
medicines in the topical treatment of psoriasis has led to extensive 
research for anti-psoriatic activities of plant-based drugs [3-5]. The 
literature survey reveals the multitude of medicinal properties of 
Azadirachta indica, Lawsonia inermis, and Mallotus philippensis for 
the treatment of skin diseases as well as absence of such 
combination therapy [6]. The dried extracts of Azadirachta indica, 
Lawsonia inermis, and Mallotus philippensis act as anti-inflammatory 
agents due to the presence of flavonoids in them [7-9]. The 
permeability through the skin is improved through the NLC 
approach due to the improved lipophilicity as imparted by solid and 
liquid lipids [10, 11]. The literature survey reveals that a maximum 
of 5-10% of the drug can be loaded in NLCs [12]. Our preliminary 
studies have shown the encouraging results for antipsoriatic 
potential of the dried extracts of Azadirachta indica, Lawsonia 
inermis, and Mallotus philippensis when loaded in Nanostructured 
Lipid Carriers [13, 14]. The present study was aimed to develope 
topical cream formulation containing the Nanostructured Lipid 
Carriers of Azadirachta indica leaves extract (AE), Lawsonia inermis 
leaves extract (LE) and fruit extract of Mallotus philippensis (ME) and 
assessing the antipsoriatic activity of prepared cream formulation 
using cell line studies and preclinical trials on animal models.  
MATERIALS AND METHODS 
Materials 
Dried herbs of Azadirachta indica Leaves, Lawsonia inermis Leaves and 
Mallotus philippensis powder were purchased from local vendors and 
authenticated (Ref No.: Bot/10/2017) from Department of Botany, 
Savitribai Phule University of Pune, India. The solid lipids were 
obtained as gift samples from Gattefosse, France. Rest all chemicals 
were of AR grade and were purchased from Sigma Aldrich.  
Preparation of AE, LE and ME NLC loaded cream  
The AE, LE and ME loaded NLCs were prepared by the Hot 
Homogenization method using High-pressure homogenizer (Nitro 
Soavi, Italy) as described in our previous research work [14]. Cream 
enriched with AE, LE and ME loaded NLCs was prepared by the 
emulsification method. The aqueous phase was added dropwise to 
the oil phase at 65 °C with constant stirring. The AE, LE, and ME 
loaded NLCs were incorporated into the cream with stirring at 5000 
rpm for 5 min using High-Speed Homogenizer (Ultra Turrex) and 
stirred to yield a cream containing a final concentration of 4.7% 
NLCs. Each 60g of w/o Glycerol monostearate, Cetostearyl alcohol-
based cream rich in vitamin E and honey with Polysorbate 80 as a 
surfactant contained 2g of AE, LE and ME loaded NLCs [8, 15]. 
Determination of pH  
The pH of NLC loaded W/O cream formulation and the cream base 
was by immersing the electrode of Digital pH meter 802 
(EQUIPTRONICS, EQ-601) to a depth of 0.5 cm in a beaker 
containing cream. The determination was carried out in triplicate 
and the average of three readings was recorded [16].  
Determination of viscosity  
The viscosity of samples of NLC loaded cream was determined on 
the plate and cone Brookfield viscometer (Model CAP 2000+2) at a 
speed of 10, 20, 50 and 100 rpm for 10 sec run time using spindle 
number 7 at 37 °C. The determinations were carried out in triplicate 
and the average of three readings was recorded [17, 18].  
Spreadability  
For the determination of spreadability, 1 gm of cream was applied in 
between two glass slides and was compressed to uniform thickness 
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by placing 500 gm weight to the pan attached to the top plate and 
was subjected to pull with the help of string attached to the hook. 
The time in which the upper glass slide moves the lower plate to 
cover a distance of 14 cmWAS noted. A shorter interval indicates 
better spreadability. The spreadability (S) was calculated using the 
formula [17, 18]:  






w-weight tied to an upper glass slide. 
l-length moved on a glass slide 
t-time taken. 
Tubeextrudability 
In the present study, the method adopted for evaluating cream 
formulation for extrude ability was based upon the quantity in 
percentage cream extruded from a tube on the application of finger 
pressure. The formulation understudy was filled in a clean, 
lacquered aluminum collapsible 5 grams tube with a nasal tip of 5 
mm opening and apply the pressure on the tube with the help of a 
finger. Tube extrudability was then determined by measuring the 
amount of cream extruded through the tip when pressure was 
applied on the tube [17, 19]. 
Drug content uniformity  
Drug content uniformity was performed according to the USP 
requirement for the cream formulation using uniformity for the 
content check Assay method by UV. In the filled tube sample was 
taken from the upper, middle and end portion and analyzed by UV 
Spectrophotometer. 3 g of each cream (equivalent 10 mg of the 
drug) formulation were taken in 50 ml volumetric flask containing 
25 ml PBS 6.8: Methanol and stirred for 30 min and allowed to stand 
for 24 h. The volume was made up to 50 ml and volume was made 
up to 50 ml with the same solvent. The drug content was determined 
by measuring the absorbance at 214, 276 and 297 nm for the 
measurement of AE, LE and ME respectively using Double-beam UV 
spectrophotometer J V-530 Jasco Corporation, Tokyo, Japan. The 
amount of drug present in the formulation was checked by the 
percentage drug content study in the formulation [18, 20]. 
In vitro cumulative % drug diffusion of AE, LE and ME NLC 
loaded cream  
The in vitro release studies were performed using DBK Franz 
diffusion cell apparatus to evaluate the release profile of AE, LE and 
ME NLC incorporated cream. Dialysis membrane 70 (Hi-Media, 
Mumbai, India) having pore size 2.4 nm and a molecular weight cut-
off 12,000 was used and mounted on the Franz diffusion cells. A 
phosphate buffer (PBS) pH 6.8: Methanol (7:3) was used as the 
receptor medium (20 ml) being stirred at 200 rpm. 100 mg of cream 
was used for the study. During the experiments, the solution in the 
receptor side was maintained at 37±0.5 °C. At predetermined time 
intervals, 1 ml of the samples were withdrawn from the receiver 
compartment and replaced by the same volume of freshly prepared 
PBS (pH 6.8): Methanol (7:3). The samples were analyzed by the UV-
Visible spectrophotometer (UV-1800, Shimadzu, Japan) at 214, 276 
and 297 nm for the release of AE, LE and ME respectively [18, 19]. 
Stability studies 
NLC based cream formulation was subjected to stability studies for 3 
mo. The formulations were filled in wide-mouth glass bottles and 
were stored at a temperature of 37±0.5 °C and 75±5%RH. These 
samples were evaluated for appearance, pH, viscosity, drug content, 
spreadability and in vitro drug release study [20, 21].  
Lipid peroxidation assay 
Lipid peroxidation assay for NLC based cream was determined 
based on the amount of Thiobarbituric acid reactive substances. 
The HepG2 cells were seeded in 24-well culture plates at an initial 
density of 2*105 cells/ml and grown to approximately 80% 
confluence. Oxidative stress was induced by treating the cells with 
freshly prepared H2O2. The cells were pretreated with samples 
(AE, LE and ME NLC loaded cream) at indicated concentrations for 
24 h. Fetal Bovine Serum-free Dulbecco's Modified Eagle's medium 
containing H2O2 (882nM) was added to each well and the cell plate 
was incubated for 24 h. The HepG2cells were lysed by using the 
freeze-thaw method. After analysis, 0.2 ml of the cell suspension 
was added to the Thiobarituric acid reagent. This mixture was 
incubated at 90 °C for 1 h, and then cooled. Four milliliters of a 
mixture of n-butanol and pyridine (15:1, v/v) were added and 
were centrifuged for15 min and the absorbance was measured at 
532 nm [22, 23].  
The percentage inhibition of lipid peroxidation was calculated using 
the following formula:  
% inhibition =
Absorbance control − Absorbance sample
Absorbance control
× 100 
Nitric oxide scavenging assay 
Accurately 200 µl of 10 mmol sodium nitroprusside and 200 µl of 
the test solution and reference standard of various concentrations 
were incubated at room temperature for 150 min. About 500 µl 
Griess reagent was added and was subjected to incubation for 10 
min at room temperature. The absorbance was measured at 546 nm. 
Test substances were replaced by Phosphate buffer solution pH 7.0 
for control [24]. 
The percentage inhibition of Nitric Oxide was calculated as follows:  
% inhibition =
Absorbance control − Absorbance sample
Absorbance control
× 100 
Cytotoxicity studies on HaCat cell lines 
HaCaT cell line was procured from ATCC, stock cells were cultured in 
Dulbecco's Modified Eagle's medium supplemented with 10% 
inactivated Fetal Bovine Serum, Penicillin (100 IU/ml), Streptomycin 
(100 µg/ml) in a humidified atmosphere of 5% Carbon dioxide at 37 °C. 
Serial two-fold dilutions (0-100µM) were prepared for carrying out 
cytotoxic studies. The monolayer cell culture was trypsinized and 
the cell count was adjusted to 1.0 x 105 cells/ml using respective 
media containing 10% Fetal Bovine Serum. To each well of the 96 
well microtiter plate, 100 µl of the diluted cell suspension (50,000 
cells/well) was added. After 24 h, when a partial monolayer was 
formed, the supernatant was discarded, washed the monolayer once 
with medium and 100 µl of different test concentrations of NLC 
loaded cream was added on to the partial monolayer in microtiter 
plates followed by incubation at 37 °C for 24 h in 5% Carbon dioxide 
atmosphere. After incubation, the test solutions in the wells were 
discarded and 100 µl of 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyl 
tetrazolium bromide (5 mg/10 ml of MTT in USP Phosphate buffer 
pH 7.0) was added to each well. The plates were incubated for 4 h at 
37 °C in 5% Carbon dioxide atmosphere. The supernatant was 
removed and 100 µl of Dimethyl sulfoxide was added and the plates 
were gently shaken to solubilize the formed formazan. The 
absorbance was measured using a microplate reader at a 
wavelength of 590 nm. The percentage growth inhibition was 
calculated using the following formula and concentration of test 
drug needed to inhibit cell growth by 50% (IC50) values were 
generated from the dose-response curves for each cell line [25, 26]. 
% inhibition = 100 −
OD of cream sample
OD of control
× 100 
DNA fragmentation studies on HaCat cell lines 
HaCat cells were seeded at a concentration of 1x106 per 35 mm 
dish incubated at 37 °C/5 % Carbon dioxide for 24 h. The 
confluent cells grown after 24 h of incubation were treated with 
sample conc.160μg/ml, 320μg/ml and control. After treatment, 
cells were trypsinized, and both adherent and floating cells were 
collected by centrifugation at 2000 rpm for 5 min. The cell pellet 
was suspended in 0.5 ml lysis buffer pH 7.8 containing a mixture 
of Tris-Hydrochloric acid 10 mmol, pH 8; Ethylene diamine 
tetraacetic acid 20 mmol, pH 8.0; TritonX-100 0.2% or Sodium-
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N-lauroyl sarcosinate, 4M Sodium chloride, vortex vigorously 
and incubated at 50 °C for 5 min. To the lysate, 0.5 ml of phenol 
chloroform iso-amyl alcohol was added and mixed for 2-3 min 
and centrifuged at 10000 rpm for 15 min at 4 °C. The upper 
aqueous layer was taken in a new tube, to which double the 
volume of cold 100% ethanol was added and 3M sodium acetate 
was added to make a final concentration of sodium acetate 0.3 M. 
The sample was incubated for 5-10 min at room temperature 
and centrifuged at 10000 rpm for 15 min. After removing the 
supernatant, the DNA pellets were washed with 70% ethanol and 
centrifuged at 5000 rpm for 10 min followed by removal of 
supernatant and air drying of DNA pellets that were dissolved in 
tris buffer and separated by 2% agarose gel electrophoresis at 
100 volts for 50 min [27, 28]. 
Mouse-tail model for psoriasis 
All procedures of the study were in accordance with the guidelines 
set by the CPCSEA and an approved IAEC protocol number (IAEC-
17-019). 15 male Swiss albino Mice were allowed to acclimatize 
for 5 d and randomly allotted to three groups, 6 mice per standard 
Group I, Clobetasol propionate 0.05% cream and AE, LE, and ME 
NLC loaded cream Group II and 6 mice for placebo control Group 
III. The samples were applied to tails treated locally at the rate of 
2-5 mg per animal to the proximal part of the tail uniformly. For 
the contact time of 2 h, a plastic cylinder was slipped over the tail 
and fixed with adhesive tape. At the end of contact time, the 
cylinders were removed and the tails were wiped with cotton. 
Mice were treated once daily, for 2 w. Two h after the last 
treatment the animals were sacrificed and the tails were fixed in 
10% buffered formalin and processed for histopathology. 
Longitudinal sections of about 5μm thickness were prepared and 
stained with hematoxylin-eosin and permanent slides were 
prepared for evaluation. Sections were examined under a light 
microscope to observe alterations in epidermal thickness, 
elongation of ridges and orthokeratosis. The animals were also 
observed for mortality and clinical sign and changes in body 
weights [29]. 
Rat ultraviolet ray B photo dermatitis model for psoriasis 
Healthy male Sprague Dawley rats weighing 150-200 gm were kept in 
12h light: 12h dark cycle at 20.4 to 23.8 °C temperature and 36 to 61 
% RH with the provision of food (ad libitum) and water (Reverse 
osmosis water treated with Ultraviolet light) were carefully 
maintained. All procedures of the study were in accordance with 
guidelines set by the CPCSEA and an approved IAEC protocol number 
(IAEC-17-009). The study design comprised of three groups, Group I 
(2-5 mg/kg of Clobetasol propionate 0.05% cream as standard) 6 
animals, Group II (2-5 mg/kg of AE, LE and ME NLC loaded cream) 6 
animals and Group III (2-5 mg/kg of Placebo cream) 3 animals 
respectively. The hair on the dorsal skin was clipped and carefully 
shaved. An area (1.5 x 2.5 cm) on one side of the flank was irradiated 
for 15 min (1.5 J/cm2) at a vertical distance of 20 cm with UV-B 
LAMPS. Biphasic erythema was observed. After 72 h irradiation, the 
test anti-psoriatic cream, standard cream, and placebo cream were 
applied at the 2-5 mg/rat topically on the irradiated site daily once. 
The irradiated rats were sacrificed on day 11 after UV-B irradiation by 
CO2 anesthesia. Skin biopsies were taken immediately, and fixed in 
10% formalin and embedded in paraffin. Tissue sections (4 μm thick) 
were stained with hematoxylin and eosin. Sections were examined 
under a light microscope to observe alterations in epidermal 
thickness, elongation of ridges and orthokeratosis. Parameters 
evaluated included mortality and clinical signs observations and body 
weight. All the data were analyzed using one way ANOVA followed by 
Dunnett’s Multiple Comparison test [30, 31].  
RESULTS AND DISCUSSION 
Evaluation of AE, LE and ME NLC loaded cream 
The literature survey reveals that a maximum of 5-10% of the drug 
can be loaded in NLCs [12]. That is 2g of NLC can contain a 
maximum of 200 mg of the drug. For loading, the NLCs in suitable 
cream base 2g of NLCs were loaded in 60g of cream base. The NLC 
loaded w/o cream was evaluated for pH, Physical appearance, Drug 
content, viscosity, spreadability, Drug diffusion, and Stability. The pH 
of NLC based cream was found to be 6.91±0.011. 
 
 
Fig. 1: Viscosity values of the AE, LE and ME NLC Incorporated cream at different rpm, Note: (n=3) all data representing an average of 3 trials, 
given as mean±SD, AE= Azadirachta indica extract, LE= Lawsonia inermis extract, ME= Mallotus phillipensis extract, NLCs= Nanolipid carriers 
 
Fig. 1 indicates that the cream formulation has the desired viscosity 
required for semisolid formulation for proper packaging. It was 
found that the viscosity decreases as the rotational speed of 
viscometer increased suggesting shear thinning/pseudoplastic 
behavior at an ambient temperature where there is a decrease in 
viscosity by increasing shear rate favours easy spreadability further 
confirmed by spreadability test and tube extrudability (table 1). This 
shear-thinning behavior is a desirable property for topical 
preparations, as they should be thin during application and thick 
otherwise.
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Table 1: Spreading coefficient and tube extrudability of the AE, LE and ME NLC incorporated cream 
S. No. AE, LE and ME NLC loaded cream 
Spreadability (gm. cm/s) Extrudability (%) 
1 46.18 7.2% 
2 46.06 7.4% 
3 46.87 7.7% 
(mean SD±,n=3) 46.37±0.43 7.43±0.25 
 
Spreadability plays a considerable role in patient compliance and 
ensures uniform application of cream to a larger area of the skin. The 
low value of the spreadability coefficient of the cream was sufficient 
suggesting easy spreading and no signs of grittiness. Extrudability is a 
measure of removal of cream from the orifice of the container. The 
lower value of spreadability and tube extrudability indicates the lesser 
work required to spread the cream over the skin, which means 
formulation was easily spreadable by applying small amount of shear. 
  
 
Fig. 2: Percentage drug content of AE, LE and ME NLC incorporated cream, Note: (n=3) all data representing an average of 3 trials, given as 
mean±SD, AE= Azadirachta indica extract, LE= Lawsonia inermis extract, ME= Mallotus phillipensis extract, NLCs= nanolipid carriers 
 
 
Fig. 3: Cumulative % drug diffusion of AE, LE and ME from NLC based Cream, Note: (n=3) all data representing an average of 3 trials, given 
as mean±SD, AE= Azadirachta indica extract, LE= Lawsonia inermis extract, ME= Mallotus phillipensis extract, NLCs= Nanolipid Carriers 
 
The results for % drug content are depicted in fig. 2 that showed 
uniform distribution of drugs throughout the cream. 
The data obtained from in vitro drug release studies also support 
and suggest complete and prolonged drug release from the NLCs 
through the cream base. During the preparation of NLCs, cooling 
from high temperature to room temperature favors the enrichment 
of the drug in the outer layers of the particles resulting in superficial 
entrapment causing initial burst release followed by prolonged drug 
release from the core of NLCs up to 24h that was found to be 
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81.24±0.51%, 74.31±0.25% and 70.43±0.78% for AE, LE and ME 
respectively as shown in fig. 3. 
Lipid peroxidation assay 
Psoriasis has been associated with oxidative stress, which in turn is 
a function of lipid peroxidation as malondialdehyde (MDA) in the 
blood of psoriatic patients. The lipid peroxidation was determined 
based on the amount of thiobarbituric acid-reactive substances 
(TBARS) and with minor modifications in the HepG2 cells [32]. 
Oxidative stress was induced by treating the cells with freshly 
prepared H2O2. The results were expressed as percentage inhibition 
of lipid peroxidation as malondialdehyde (MDA) per milligram of 
protein. Lipid peroxidation Inhibition of the topical cream 
formulation of the NLCs with IC50 being 1497.3μg/ml. The results 
suggest inhibition of lipid peroxidation in the prepared NLC 
incorporated cream containing a combination of the extracts of AE, 
LE and ME. Fig. 4 depicts the Anti-lipid peroxidation activity of AE, 
LE and ME from NLC based Cream. 
  
 
Fig. 4: Lipid peroxidation Inhibition of AE, LE and ME loaded NLCs based cream, Note: AE= Azadirachta indica extract, LE= Lawsonia 
inermis extract, ME= Mallotus phillipensis extract, NLCs= Nanolipid Carriers, MDA= Malondialdehyde 
 
Nitric oxide scavenging assay 
Nitric oxide is a gaseous free radical that can react with superoxide 
anion and give rise to powerful free radicals called peroxynitrite 
radicals (NOO). It appears that the overproduction of uncontrolled 
formation peroxynitrite is an important factor in tissue-damaging 
mechanisms in chronic inflammation in psoriatic patients. This 
assay was performed to assess the anti-inflammatory effect of the 
selected drugs and formulations during the treatment of psoriasis. 
Sodium nitroprusside in aqueous solution at physiological pH 
spontaneously generates nitric oxide, which interacts with oxygen to 
produce nitrite ions that can be measured using Griess reagent at 
546 nm [33]. The percentage inhibition of Nitric Oxide was 
calculated. The results were expressed as Nitric Oxide Inhibition of 
AE, LE and ME NLC loaded cream that was observed to increase with 
the increase in dose as depicted in fig. 5. The AE, LE and ME NLC 
based cream possessed the Nitric Oxide Scavenging capability with 
an IC50 value of 697.9μg/ml. 
 
 
Fig. 5: Nitric oxide scavenging activity of AE, LE and ME NLC based cream, Note: AE= Azadirachta indica extract, LE= Lawsonia inermis 
extract, ME= Mallotus phillipensis extract, NLCs= Nanolipid Carriers 
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Cytotoxicity studies for HaCat cell lines  
Psoriasis results from the hyper proliferation and abnormal 
differentiation of keratinocytes. The AE, LE and ME loaded NLC 
based cream were evaluated for anti-proliferative activities by MTT 
assay and found to have significant anti-proliferative effects, with 
IC50 being 181.7μg/ml.  
DNA fragmentation studies on HaCat cell lines 
In the present investigation, we explored the propensity of 
keratinocytes derived from psoriatic plaques to undergo apoptosis. 
DNA fragmentation into oligonucleosomal ladders is characteristic 
of apoptosis. DNA fragmentations for AE, LE and ME loaded NLC 
based cream formulation was analyzed by gel electrophoresis. HaCat 
cells treated with samples of the topical cream formulation of the 
NLCs in the prescribed doses of 160μg/ml, 320μg/ml have shown 
dose-dependent increased DNA Fragmentation as compared with 
control. Overall, these results suggest that the DNA fragmentations 
were induced, a marker of apoptotic activity in the Cream. 
Mousetail model for psoriasis 
Advanced anti-psoriatic studies on animal models for topical cream 
loaded with AE, LE ad ME NLCs were conducted to evaluate and 
compare the safety and efficacy of nanoparticulate anti-psoriatic 
cream versus Clobetasol propionate 0.05% cream as topical 
applications in (psoriasis) using mouse tail method. 
Compared with the normal control group, the epidermal thickness of 
mice tail skin treated with the standard drug (clobetasol propionate 
0.05% cream) and test drug (AE, LE and ME loaded NLC based 
cream) groups were markedly reduced. Based on the results of the 
present study, it can be concluded that formulations of standard 
drug and test drugs may have potential anti-psoriatic activity.  
Rat ultraviolet ray-B photodermatitis model for psoriasis 
Rat Ultraviolet Ray-B photodermatitis model was applied to evaluate the 
antipsoriatic potential of nanoparticulate anti-psoriatic cream versus 
Clobetasol propionate 0.05% cream. Compared with the normal control 
group, the epidermal thickness of rat skin treated with standard drug 
(clobetasol propionate 0.05% cream) and test drug (AE, LE and ME 
loaded NLC based cream) groups were marked reduction in the 
thickness of the epidermal layer and inflammatory changes. Based on 
the results of the present study, it can be concluded that formulations of 
standard drug and test drugs may have potential anti-psoriatic activity.  
CONCLUSION 
The polyherbal nanoparticulate cream was successfully developed 
that met the relevant pharmaceutical characteristics. The cream 
possessed definite anti-proliferative activity against the HaCat cell 
lines. The experiments conducted under advanced pre-clinical trials 
confirmed the ability of the cream to suppress inflammation. 
Therefore, AE, LE and ME loaded NLC based cream could be 
considered as a potent and inexpensive anti-psoriatc agent. From 
the data obtained, it can be concluded that the developed AE, LE and 
ME loaded NLC based cream can be used for prolonged topical 
delivery of drugs for the management of Psoriasis and is a potential 
candidate for conducting further clinical studies. 
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